These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32662926)

  • 1. Second-Generation Meridianin Analogues Inhibit the Formation of Mycobacterium smegmatis Biofilms and Sensitize Polymyxin-Resistant Gram-Negative Bacteria to Colistin.
    Zeiler MJ; Melander RJ; Melander C
    ChemMedChem; 2020 Sep; 15(17):1672-1679. PubMed ID: 32662926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Function Studies on IMD-0354 Identifies Highly Active Colistin Adjuvants.
    Nemeth AM; Basak AK; Weig AW; Marrujo SA; Barker WT; Jania LA; Hendricks TA; Sullivan AE; O'Connor PM; Melander RJ; Koller BH; Melander C
    ChemMedChem; 2020 Jan; 15(2):210-218. PubMed ID: 31756025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 6. Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria.
    Barker WT; Chandler CE; Melander RJ; Ernst RK; Melander C
    Bioorg Med Chem; 2019 May; 27(9):1776-1788. PubMed ID: 30898435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening an Established Natural Product Library Identifies Secondary Metabolites That Potentiate Conventional Antibiotics.
    Mattingly AE; Cox KE; Smith R; Melander RJ; Ernst RK; Melander C
    ACS Infect Dis; 2020 Oct; 6(10):2629-2640. PubMed ID: 32810395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvants restore colistin sensitivity in mouse models of highly colistin-resistant isolates, limiting bacterial proliferation and dissemination.
    Koller BH; Jania LA; Li H; Barker WT; Melander RJ; Melander C
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0067124. PubMed ID: 39194205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
    Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
    Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syzygium aromaticum (clove) and Thymus zygis (thyme) essential oils increase susceptibility to colistin in the nosocomial pathogens Acinetobacter baumannii and Klebsiella pneumoniae.
    Vázquez-Ucha JC; Martínez-Guitián M; Lasarte-Monterrubio C; Conde-Pérez K; Arca-Suárez J; Álvarez-Fraga L; Pérez A; Crecente-Campo J; Alonso MJ; Bou G; Poza M; Beceiro A
    Biomed Pharmacother; 2020 Oct; 130():110606. PubMed ID: 32795924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
    Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
    Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Han ML; Chen K; Onufrak NJ; Wang J; Turnidge JD; Howden BP; Forrest A; Chan HK; Li J
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
    Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.
    Huggins WM; Barker WT; Baker JT; Hahn NA; Melander RJ; Melander C
    ACS Med Chem Lett; 2018 Jul; 9(7):702-707. PubMed ID: 30034604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins.
    Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Class of Adjuvants Enables Lower Dosing of Colistin Against Acinetobacter baumannii.
    Minrovic BM; Jung D; Melander RJ; Melander C
    ACS Infect Dis; 2018 Sep; 4(9):1368-1376. PubMed ID: 29890069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple Dipyrrin Analogues of Prodigiosin for Use as Colistin Adjuvants.
    Siwawannapong K; Nemeth AM; Melander RJ; Rong J; Davis JR; Taniguchi M; Carpenter ME; Lindsey JS; Melander C
    ChemMedChem; 2022 Aug; 17(16):e202200286. PubMed ID: 35704751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the in vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care centre in Western Turkey.
    Ece G; Samlioglu P; Atalay S; Kose S
    Infez Med; 2014 Mar; 22(1):36-40. PubMed ID: 24651089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule downregulation of PmrAB reverses lipid A modification and breaks colistin resistance.
    Harris TL; Worthington RJ; Hittle LE; Zurawski DV; Ernst RK; Melander C
    ACS Chem Biol; 2014 Jan; 9(1):122-7. PubMed ID: 24131198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.